» Articles » PMID: 38619752

The Emerging Role of CARM1 in Cancer

Overview
Publisher Springer
Date 2024 Apr 15
PMID 38619752
Authors
Affiliations
Soon will be listed here.
Abstract

Coactivator-associated arginine methyltransferase 1 (CARM1), pivotal for catalyzing arginine methylation of histone and non-histone proteins, plays a crucial role in developing various cancers. CARM1 was initially recognized as a transcriptional coregulator by orchestrating chromatin remodeling, transcription regulation, mRNA splicing and stability. This diverse functionality contributes to the recruitment of transcription factors that foster malignancies. Going beyond its established involvement in transcriptional control, CARM1-mediated methylation influences a spectrum of biological processes, including the cell cycle, metabolism, autophagy, redox homeostasis, and inflammation. By manipulating these physiological functions, CARM1 becomes essential in critical processes such as tumorigenesis, metastasis, and therapeutic resistance. Consequently, it emerges as a viable target for therapeutic intervention and a possible biomarker for medication response in specific cancer types. This review provides a comprehensive exploration of the various physiological functions of CARM1 in the context of cancer. Furthermore, we discuss potential CARM1-targeting pharmaceutical interventions for cancer therapy.

References
1.
Espinosa L, Cathelin S, DAltri T, Trimarchi T, Statnikov A, Guiu J . The Notch/Hes1 pathway sustains NF-κB activation through CYLD repression in T cell leukemia. Cancer Cell. 2010; 18(3):268-81. PMC: 2963042. DOI: 10.1016/j.ccr.2010.08.006. View

2.
An W, Kim J, Roeder R . Ordered cooperative functions of PRMT1, p300, and CARM1 in transcriptional activation by p53. Cell. 2004; 117(6):735-48. DOI: 10.1016/j.cell.2004.05.009. View

3.
Lim C, Alkon D . Protein kinase C stimulates HuD-mediated mRNA stability and protein expression of neurotrophic factors and enhances dendritic maturation of hippocampal neurons in culture. Hippocampus. 2012; 22(12):2303-19. DOI: 10.1002/hipo.22048. View

4.
Hong H, Kao C, Jeng M, Eble J, Koch M, Gardner T . Aberrant expression of CARM1, a transcriptional coactivator of androgen receptor, in the development of prostate carcinoma and androgen-independent status. Cancer. 2004; 101(1):83-9. DOI: 10.1002/cncr.20327. View

5.
Greenblatt S, Man N, Hamard P, Asai T, Karl D, Martinez C . CARM1 Is Essential for Myeloid Leukemogenesis but Dispensable for Normal Hematopoiesis. Cancer Cell. 2018; 33(6):1111-1127.e5. PMC: 6191185. DOI: 10.1016/j.ccell.2018.05.007. View